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ABSTRACT 
 
Recently, artificial microRNA (miRNA)-mediated RNA interference (RNAi) systems have been developed as 
useful tools to study gene functions. We report an artificial miRNA precursor motif (AMPM) containing 
several  restriction  sites  in  the  loop  and  in  the  extended  stem  structures,  and  generated  a  vector-based 
expression system for AMPM under the control of an RNA polymerase II promoter. The AMPM located in 
the  intron  or  the  exon  of  the  selection  marker  gene  mediated  silencing  of  the  reporter  luciferase  gene 
expression  in  HeLa  cells.  Northern  blotting  and  colony  formation  assays  revealed  that  the  AMPM  was 
efficiently  and  appropriately  processed  into  mature  miRNA.  The  AMPA  system  also  down-regulated 
endogenous p53 and laminA/C proteins in stable transfectants. Moreover, clustered AMPMs separated by an 
appropriate  spacer,  targeting  different  sites  within  a  single  mRNA  mediated  gene  silencing,  even  if  the 
sequences of the target and the AMPM were partially complementary. This indicates the potential therapeutic 
utility of clustered AMPMs for highly-mutable targets, such as human immunodeficiency virus type 1. 
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INTRODUCTION 
 
RNA  interference  (RNAi)  is  now  a  powerful  tool  to 
suppress  gene  expression  in  various  eukaryotic  systems 
(Murchison and Hannon, 2004; Filipowicz, 2005; Sandy et 
al,  2005).  In  mammalian  cells,  chemically  synthesized 
small interfering RNAs (siRNAs) and vector-based short 
hairpin  RNAs  (shRNAs),  which  are  processed  by  a 
cytoplasmic endonuclease, Dicer, into siRNAs, have been 
used to mediate RNAi. Cells express small single-stranded 
RNAs 20-24 nucleotides (nt) in length, called microRNAs 
(miRNAs) (Lagos-Quintana et al, 2001; Lau et al, 2001; 
Lee  and  Ambros,  2001),  which  mediate  gene  silencing 
similarly to shRNAs (Bartel, 2004). miRNAs are encoded 
within  intergenic  regions  and  intronic  regions  of  the 
eukaryotic genome, and are sometimes clustered (Altuvia 
et  al,  2005;  He  et  al,  2005).  Initially,  miRNAs  are 
transcribed  as  a  part  of  long  precursor  RNA  (primary-
miRNA or pri-miRNA) (Lee et al, 2002; Suh et al, 2004; 
He  et  al,  2005),  and  form  a  hairpin-like  structure.  A 
nuclear  endonuclease,  Drosha,  processes  this  stem-loop 
structure  into  miRNA  precursors  (pre-miRNAs)  ~70  nt 
long  (Zeng  et  al,  2005b).  The  nuclear  pre-miRNAs  are 
exported to the cytoplasm by a nuclear transport receptor, 
Exportin-5  (Yi  et  al,  2003;  Bohnsack  et  al,  2004),  and 
processed  by  Dicer  into  mature  miRNAs  ~22  nt  long. 
After incorporation into miRNA-containing RNA-induced 
silencing complexes, miRNAs bind to their target mRNAs 
with  partial  complementarity,  and  direct  degradation  of 
mRNA and/or translational suppression (Yekta et al, 2004; 
Bagga et al, 2005; Petersen et al, 2006). 
 
Effective gene silencing in cultured cells (Zeng et al, 2002; 
Boden  et  al,  2004;  Stegmeier  et  al,  2005;  Zeng  et  al, 
2005a; Zhou et al, 2005; Chung et al, 2006) and mice (Li 
et  al,  2006:  Rao  et  al,  2006;  Xia  et  al,  2006)  using 
expression  vectors  for  artificially  designed  miRNA 
precursors is well documented. In these reports, expression 
vectors for synthetic miRNA precursors were constructed 
by  substitution  of  the  stem  regions  of  natural  miRNA 
precursors,  such  as  miR-30  or  miR-155,  to  fully  match 
arbitrary target mRNAs, but the loop sequences remained  
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intact. Here we designed a novel artificial miRNA, named 
AMPM, which incorporates restriction enzyme recognition 
sequences  in  the  loop  and  stem  region  of  the  miRNA 
precursor structure. Despite the absence of any sequence 
of  natural  miRNA  precursors,  AMPMs  were  efficiently 
processed into mature miRNAs and suppressed the target 
gene expression. We also assessed the ability of dicistronic 
AMPM  clusters  targeting  multiple  sites  within  a  single 
mRNA to suppress highly-mutable targets. The usefulness 
of AMPM as a gene silencing tool is discussed. 
 
MATERIALS AND METHODS 
 
Target site selection and AMPM design 
The  sequences  of  the  GL3  firefly  luciferase  gene,  the 
human p53 mRNA, the human lamin A/C mRNA and the 
HIV-1 genome were obtained from GenBank (GenBank 
accession  Nos.  U47296,  NM000546,  NM170707  and 
AF033819, respectively). The target site of the GL3 firefly 
luciferase  included  the  target  site  of  shRNA  used  in  a 
previous report (Elbashir et al, 2001). The target sites of 
other  genes  were  selected  using  the  siRNA  design  tool 
freely  provided  by  QIAGEN  on  the following  website:- 
(http://www1.qiagen.com/Products/GeneSilencing/Custom
SiRna/SiRnaDesigner.aspx).  This  design  tool  makes 
choices of 21 nt long target sites of siRNAs based on an 
original  score.  Endogenous  miRNA  precursors  are 
processed  at  positions  22~26  nt  from  their  stem-loop 
junctions by Drosha (Weber, 2005). We therefore selected 
26-nt  target  sequences.  The  antisense  regions  of  all 
AMPMs  used  in  this  study  were  designed  to  be  fully 
complementary to their target mRNAs. The sense regions 
were modified to form a mismatch and a bulge structure in 
their stem regions and G-U wobble pairs in the 3’ half of 
the  stem  regions.  Secondary  structure  of  AMPMs  was 
predicted using the program mfold (ver 3.2) (Zuker, 2003). 
(http://www.bioinfo.rpi.edu/applications/mfold/rna/form1.cgi). 
 
Plasmid construction 
Oligonucleotides used in plasmid construction are given in 
Table  1.  To  construct  a  parent  vector  for  the  AMPM 
cassette,  the multiple cloning site (MCS)  of pBluescript 
SK (+) (Stratagene) was replaced by a novel MCS in two 
steps. A pair of chemically  synthesized oligonucleotides 
was first annealed to form MCS1 and inserted into the Kpn 
I-Eco RI site, and then MCS2 was similarly produced and 
inserted into the Eco RI-Xba I site of pBluescript SK (+). 
The  resulting  plasmid  was  designated  as  pBS-miR.  To 
generate  the  AMPM-FL  cassette,  oligonucleotides 
corresponding to the antisense strand region (AMPM-FL-
A) and the modified sense strand region (AMPM-FL-mS) 
were  inserted  into  the  pBS-miR  vector.  After  digestion 
with  Pvu  II  and  Eco  RV,  the  AMPM-FL  cassette  was 
inserted into the blunted Bam HI site and the Nae I site in 
pVITRO1 (Invivogen), generating the exonic and intronic 
AMPM  vectors,  pAMPM-FL-exon  and  pAMPM-FL-
intron,  respectively.  Other  AMPM  vectors  targeting  the 
human  p53  mRNA,  the  human  lamin  A/C,  the  HIV-1 
integrase and the HIV-1 capsid genes were constructed in 
a similar manner using appropriate oligonucleotides given 
in  Table  1.  Human  H1  promoter-driven  shRNA  vectors 
targeting the HIV-1 integrase and capsid genes, pH1-sh-
IN1  and  pH1-sh-CA1,  were  constructed  using 
oligonucleotide pairs sh-IN1, and sh-CA1, respectively, as 
previously  described (Brummelkamp et al, 2002) except 
that the stem regions we used were 26 bp long. 
 
The clusters of AMPM cassettes were constructed in pBS-
miR. A pair of oligonucleotides, INT, consisting of partial 
sequence  of  an  interval  sequence  in  the  human  miR-17 
cluster  on  chromosome  13  (GenBank  accession  No. 
AB176708),  and  an  Eco  RV  recognition  sequence,  was 
inserted into the Eco RV-Xba I site of pBS-AMPM-IN1. 
The Eco RV site was used for further concatenation of the 
interval  sequence  unit,  which was 24  bp  in  length.  The 
AMPM-IN1  cassette,  obtained  by  digestion  of  pBS-
AMPM-CA1 with Pvu II and Xba I, was inserted into the 
Eco RV-Xba I site of pBS-AMPM vectors containing the 
AMPM-IN  cassette  and  various  lengths  of  interval 
sequences.  The  AMPM  cluster  vectors  containing  the 
AMPM-IN1 and AMPM-CA1 cassettes were constructed 
in a similar manner. 
 
Series  of  reporter  vectors,  pFL-INs and  pFL-CAs, were 
constructed  as  follows.  Partial  sequences  encoding 
integrase (IN) and p24 capsid protein (CA) from several 
strains of HIV-1 were inserted into the Xba I site located 
in  the  3’-UTR  7  bp  downstream  from  the  GL3  firefly 
luciferase open reading frame in the pGL3-Control vector 
(Promega).  The  IN1  and  CA1  sequences  were  selected 
from  an  HIV-1  strain  (GenBank  accession  No. 
AF033819).  The  sequences  corresponding  to  IN1  from 
different strains of HIV-1, IN2, IN3 and IN4 were from 
GenBank  accession  Nos.  AF484511,  AY713418  and 
AF055729,  respectively.  The  sequences  CA2,  CA3  and 
CA4 corresponding to CA1 were from GenBank accession 
Nos. AY134925, AY396897 and AY489925, respectively. 
To generate pFL-IN1-CA1, IN2-CA2, IN3-CA3 and IN4-
CA4,  oligonucleotides  IN1,  IN2,  IN3  and  IN4  were 
inserted into the Xba I site in the pFL-CA1, CA2, CA3 and 
CA4 vectors, respectively. 
 
Cell culture and transfection 
HeLa  cells  were  grown  in  DMEM  (Sigma-Aldrich) 
supplemented with 10% (v/v) heat-inactivated fetal bovine 
serum (JRH Biosciences) and plated at 2 x 10
5 cells per 
well in 12-well plates or 4 x 10
5 cells per well in 6-well 
plates  24  hr  prior  to  transfection.  The  cells  were 
transfected using Lipofectamine Plus reagent (Invitrogen) 
according to the manufacturer’s instructions. 
 
To isolate stable transfectants, HeLa cells transfected with 
pAMPM-p53 or pAMPM-lamin A/C were replated in 100-
mm dishes 24 hr post-transfection, and cultured with 200 
µg/ml  of  hygromycin  (Wako)  for  2  weeks.  Thereafter, 
colonies were counted, isolated and propagated. 
 
Northern blot analysis 
The chemically synthesized DNA oligonucleotide probes 
to  detect  the  antisense  strand  region  of  AMPMs  are  as 
follows: 
 
AMPM-FL: 
5’-ATCACTTACGCTGAGTACTTCGAAATGT-3’ 
 
AMPM-p53: 
5’-CTGGAAGACTCCAGTGGTAATCTACT-3’  
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Table 1.  Oligonucleotides for plasmid vector construction 
 
Name  Sense 5’ ￿ ￿ ￿ ￿ 3’  Antisense 5’ ￿ ￿ ￿ ￿ 3’ 
Oligonucleotides for pBS-ArmiR   
MCS1  CGGATCCCAGCTGCTCGAGGGATCCACTAGTG  AATTCACTAGTGGATCCCTCGAGCAGCTGGGATCCGGTAC 
MCS2  AATTCAGATCTGTCGACCAGGATATCAAGCTTT  CTAGAAAGCTTGATATCCTGGTCGACAGATCTG 
Oligonucleotides for ArmiR cassettes   
ArmiR-FL-A  TCGAGACATTTCGAAGTACTCAGCGTAAGTGATA  CTAGTATCACTTACGCTGAGTACTTCGAAATGTC 
ArmiR-FL-mS  AATTCCACTTCCGCTGGTACTTTGAAATGTG  TCGACACATTTCAAAGTACCAGCGGAAGTGG 
ArmiR-p53-A  TCGAGAGTAGATTACCACTGGAGTCTTCCAGTTA  CTAGTAACTGGAAGACTCCAGTGGTAATCTACTC 
ArmiR-p53-mS  AATTCCTGGACGACTCAGTGGTAATTTATTG  TCGACAATAAATTACCACTGAGTCGTCCAGG 
ArmiR-Lamin AC-A  TCGAGTGTAGATGTTCTTCTGGAAGTCCAGTTTA  CTAGTAAACTGGACTTCCAGAAGAACATCTACAC 
ArmiR-Lamin AC-mS  AATTCACTGGCCTTCCGAAGAATATTTATAG  TCGACTATAAATATTCTTCGGAAGGCCAGTG 
ArmiR-CA1-A  TCGAGATCATTTCTTCTAGTGTAGCCGCTGGCTA  CTAGTAGCCAGCGGCTACACTAGAAGAAATGATC 
ArmiR-CA1-mS  AATTCCCAGCAGCTACCTAGAAGAAATGATG  TCGACATCATTTCTTCTAGGTAGCTGCTGGG 
ArmiR-IN1-A  TCGAGGAAAATATGCTGTTTCCTGCCCTGTTCTA  CTAGTAGAACAGGGCAGGAAACAGCATATTTTCC 
ArmiR-IN1-mS  AATTCAACAGTGCAGGAACAGCATATTTTTG  TCGACAAAAATATGCTGTTCCTGCACTGTTG 
Oligonucleotides for shRNA vectors   
Sh-IN1  GATCCCCGAAAATATGCTGTTTCCTGCCCTGTTTTCAAG  AGCTTTTCCAAAAAGAAAATATGCTGTTTCCTGCCCTGT 
  AGAAACAGGGCAGGAAACAGCATATTTTCTTTTTGGAAA  TTCTCTTGAAAACAGGGCAGGAAACAGCATATTTTCGGG 
Sh-CA1  GATCCCCATCATTTCTTCTAGTGTAGCCGCTGGTTCAAG  AGCTTTTCCAAAAAATCATTTCTTCTAGTGTAGCCGCTG 
    AGACCAGCGGCTACACTAGAAGAAATGATTTTTTGGAAA  GTCTCTTGAACCAGCGGCTACACTAGAAGAAATGATGGG 
Oligonucleotides for interval sequence in ArmiR cluster   
INT  CATCCAATAATTCAAGCCAAAGATATCAAGCTTT  CTAGAAAGCTTGATATCTTTGGCTTGAATTATTGGATG 
Oligonucleotides for target sequences of HIV-1   
IN1  CTAGAAACAGGGCAGGAAACAGCATATTTTCC  CTAGGGAAAATATGCTGTTTCCTGCCCTGTTT 
IN2  CTAGAAACAGGGCAGGAAACAGCCTATTTTCC  CTAGGGAAAATAGGCTGTTTCCTGCCCTGTTT 
IN3  CTAGAAACAGGGCAAGAAACAGCCTATTTTCC  CTAGGGAAAATAGGCTGTTTCTTGCCCTGTTT 
IN4  CTAGAAACAGGACAAGAAACTGCCTATTTTCC  CTAGGGAAAATAGGCAGTTTCTTGTCCTGTTT 
CA1  CTAGACCAGCGGCTACACTAGAAGAAATGATC  CTAGGATCATTTCTTCTAGTGTAGCCGCTGGT 
CA2  CTAGACCAGCGGCTACCCTAGAAGAAATGATC  CTAGGATCATTTCTTCTAGGGTAGCCGCTGGT 
CA3  CTAGACCAGCAGCTACCCTAGAAGAAATGATC  CTAGGATCATTTCTTCTAGGGTAGCTGCTGGT 
CA4  CTAGACCAGGAGCCTCCTTAGAAGAAATGATC  CTAGGATCATTTCTTCTAAGGAGGCTCCTGGT 
 
 
 
 
AMPM-lamin A/C: 
5’-ACTGGACTTCCAGAAGAACATCTACA-3’ 
 
AMPM-IN1: 
5’-AACAGGGCAGGAAACAGCATATTTTC-3’ 
 
AMPM-CA1: 
5’-CCAGCGGCTACACTAGAAGAAATGAT-3’ 
 
A probe for the modified sense strand region of AMPM-
FL  was  5’-ACATTTCAAAGTACCAGCGGAAGTG-3’. 
These  probes  were  labeled  with  γ-
32P  ATP  (MP 
Biomedicals) using T4 polynucleotide kinase (TOYOBO). 
HeLa cells  were  grown  in  6-well  plates  and transfected 
with  8  µg  of  each  plasmid  per  well.  After  48  hr  of 
transfection,  the cells  were  harvested and  used for total 
RNA  extraction  using  Isogen  (Nippongene).  Twenty 
microgram total RNA was separated by electrophoresis in 
a  15%  (w/v)  polyacrylamide/8M  urea  gel,  and  electro-
transferred  onto  a  Hybond-N+  membrane  (Amersham 
Pharmacia Biotech). After UV crosslinking, the membrane 
was hybridized with the 
32P-labeled DNA oligonucleotide 
probe in Church solution (1 mM EDTA, 0.5 M phosphate 
buffer  and  7%  (w/v)  SDS)  at  37˚C  overnight.  Washing 
was carried out at 37˚C twice in 2 x SSC and 0.1% (w/v) 
SDS for 15 min. The signals were detected using the FLA-
8000 (Fujifilm). 
 
Luciferase assay 
HeLa cells were transfected in 24-well culture plates with 
2 µg of either AMPM expression vector or mock vector, 
0.2 µg of the pGL3-Control (Promega), pFL-IN1-4, pFL- 
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CA1-4 or pFL-IN1-4-CA1-4 reporter vectors, and 0.1 µg 
of the pRL-TK (Promega) transfection control vector. The 
cells  were  harvested  at  48  hr    post-transfection.  The 
luciferase  activities  were  measured  with  the  Dual 
Luciferase  assay  kit  (Promega)  using  a  Lumat  LB9501 
luminometer  (Berthold).  The  luciferase  activity  was 
defined  as  the  ratio  of  the  reporter  firefly  luciferase 
activity to the internal control Renilla luciferase activity. 
 
RT-PCR 
Total  RNA  was  extracted  as  described  above.  Reverse 
transcription was carried out using a GeneAmp RNA PCR 
kit  (Applied  Biosystems)  with  random  hexamer  primer 
according to the manufacturer’s instructions. Polymerase 
chain  reactions  were  carried  out  with  the  following 
primers:  5’-TCTTTTTCGCAACGGGTTT-3’  and  5’-
GACCTCCGGTCACCTATTCA-3’  for  the  hygromycin 
resistance  gene  (Hyg
r)  (cycling  parameters:  94
oC  for  2 
min, followed by 28 cycles of 94
oC for 20sec, 55
oC for 10 
sec, 72
oC for 30 sec, and a final extension step of 72
oC for 
5 min) and 5’-GTCAGTGGTGGACCTGACCT-3’ and 5’-
AGGGGTCTACATGGCAACTG-3’  for  glyceraldehyde-
3-phosphate  dehydrogenase  (GAPDH)  (cycling 
parameters: 94
oC for 2 min, followed by 28 cycles of 94
oC 
for 20sec, 60
oC for 10 sec, 72
oC for 30 sec, and a final 
extension  step  of  72
oC  for  5  min.  PCR  products  were 
separated in a 1.5% (w/v) agarose gel by electrophoresis, 
and photographed after staining with ethidium bromide. 
 
Western blot analysis 
HeLa cells stably expressing AMPMs against endogenous 
targets, the p53 or lamin A/C gene, were harvested and 
lysed  in  SDS  sample  buffer.  Cell  pellets  were 
homogenized by brief sonication and protein content was 
determined by modified Lowry’s procedure (Markwell et 
al,  1978).  Twenty  micrograms  of  total  proteins  were 
separated  on  12.5%  (w/v)  SDS–PAGE  gels  and 
electrophoretically blotted onto Immobilon-P membranes 
(Millipore). Proteins were detected using specific primary 
antibodies,  peroxidase-labeled  secondary  antibodies  and 
the  ECL  Plus  Western  Blotting  Detection  System 
(Amersham  Biosciences),  and photographed  using  LAS-
1000 (Fujifilm). The primary antibodies were mouse anti-
p53 monoclonal antibody (DO-1) (Santa Cluz), rabbit anti-
lamin A/C polyclonal antibody (H-110) (Santa Cluz) and 
rabbit anti-GAPDH polyclonal antibody (FL-335)  (Santa 
Cluz), which were used at dilutions of 1:400, 1:800 and 
1:200,  respectively.  The  secondary  antibodies  were 
horseradish  peroxidase-linked  sheep  anti-mouse  Ig  and 
donkey anti-rabbit Ig antibodies (Amersham Bioscience), 
which  were  used  at  dilutions  of  1:5000  and  1:8000, 
respectively. We used the immuno-reactivity of GAPDH 
as  an  internal  control.  We  quantified  the  signals  in  the 
resulting  blots  by  densitometric  analysis  using  Image 
Gauge (Fujifilm). 
 
RESULTS 
 
Design of the artificial miRNA precursors and cloning 
of the AMPM cassettes 
AMPMs against the GL3 firefly luciferase (AMPM-FL), 
human p53 (AMPM-p53) and human lamin A/C (AMPM-
lamin A/C) genes were designed and their sequences and a 
predicted  secondary  structures  are  shown  in  Figure  1A. 
The target sites of AMPMs were selected as described in 
Materials and Methods. AMPMs were designed to mimic 
the  secondary  structure  of  the  human  miR-21  precursor 
(Zeng et al., 2005b) but they do not contain any sequence 
of miR-21 or any other endogenous miRNAs. Since a loop 
of >10 nt is essential for effective processing by Drosha 
(Zeng  et  al.,  2005b),  we  used  neighboring  restriction 
sequences, Spe I and Eco RI, as the loop. The first two 
nucleotides of the loop structure were substituted to form a 
loop of 14 nt long in the mfold estimations. The antisense 
regions  of  AMPMs  were  designed  to  be  fully 
complementary  to  the  target  sequences,  but  cytosine 
residues in the  3’ half  of the sense strand regions were 
substituted  by  uridine  residues  to  enhance  asymmetric 
incorporation of the antisense strand into RISC, so called 
‘strand  bias’  (Khvorova  et  al,  2003).  Additionally,  a 
mismatch and a bulge structure in their stem regions were 
produced by modification of the sense strand sequences to 
mimic miR-21. At the terminus of AMPM, a part of the 
Pvu II and Xho I sequences at the 5’ terminus and the Sal I 
site and additional CAG sequences at the 3’ terminus form 
an  extended  double-stranded  region.  We  confirmed  the 
secondary structures of AMPM, including a mismatch and 
a bulge structure in the stem region and a loop of 14 nt by 
mfold analysis. 
 
Prior to construction of the AMPM expression system, we 
prepared  a  cloning  vector,  pBS-miR,  containing  multiple 
cloning sites appropriate for the construction of an AMPM 
cassette.  The  oligonucleotides  corresponding  to  the 
antisense region of the target gene and its modified sense 
region were introduced into the Xho I-Spe I and Eco RI-Sal 
I sites, respectively, generating pBS-AMPM (Figure 1B).  
 
Construction of the artificial miRNA expression system 
We  generate  an  AMPM  expression  vector  under  the 
control of the EF1a promoter, we initially constructed an 
AMPM cassette targeting GL3 firefly luciferase (AMPM-
FL). The AMPM-FL cassette (Figure 1) was excised from 
pBS-AMPM-FL by digestion with Pvu II and Eco RV, and 
was  then  inserted  into  either  the  exon  (5’-UTR)  or  the 
intron of Hyg
r in pVITRO1. The resulting plasmids were 
designated  pAMPM-FL-exon  and  pAMPM-FL-intron, 
respectively (Figure 2A). 
 
To assess whether AMPM was appropriately processed into 
the  mature  miRNA,  pAMPM-FL-exon  and  pAMPM-FL-
intron were transfected into HeLa cells and the total RNA 
was isolated. Northern blot analysis showed a single band 
around 22 nt in length due to the expression of a shortly 
processed  antisense  region  of  AMPM-FL  from  both 
AMPM-FL  vectors  (Figure  2B).  This  data  suggests  that 
AMPM-FL  is  recognized  as  miRNA  precursor  and 
processed  into  mature  miRNA,  probably  by  Drosha  and 
Dicer, regardless the location within a transcript. Moreover, 
a  strand  bias  was  observed  because  RNA  molecule 
corresponding  to  the  modified  sense  region  could  not  be 
detected by northern blot analysis (data not shown). 
 
When  the  AMPM-FL  vectors  were  transfected  together 
with the firefly luciferase reporter vector, luciferase assays 
showed   that   both   vectors   effectively   suppressed   the   
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Figure 1. AMPM design and construction of AMPM cassettes. A. Nucleotide sequence and predicted secondary structure of AMPMs 
targeting the GL3 firefly luciferase (AMPM-FL), human p53 (AMPM-p53) and human lamin A/C (AMPM-lamin A/C) genes. The 
secondary structures of AMPMs were predicted using mfold program (see Materials and Methods). Each AMPM is composed of a 14 
nt loop, a stem region containing a mismatch and a bulge structure, and an extended stem region containing two mismatches. The 
antisense regions indicated as red letters are fully complementary to the target sequences. The modified sense regions are indicated as 
blue letters. B. The schematic representation of the construction of the AMPM cassette. The multiple cloning sites of the parental 
vector, pBS-miR, are shown at the top. The oligonucleotide fragments containing the antisense region (red letters) and the modified 
sense region (blue letters) of AMPM were inserted into pBS-miR in two steps to generate the pBS-AMPM vectors. 
 
 
 
luciferase  activity  (Figure  2C),  suggesting  that  both  the 
exonic  and  the  intronic  AMPMs  can  mediate  gene 
silencing. 
 
RT-PCR analysis showed that Hyg
r was expressed from 
the  pAMPM-FL-intron  as  well  as  the  empty  control 
vector, but not from the pAMPM-FL-exon vector (Figure 
2D).  The  expression  of  Hyg
r  was  further  confirmed  by 
colony  formation  assays.  HeLa  cells  transfected  with 
pAMPM-FL-intron normally formed colonies for 2 weeks 
under  hygromycin  selection,  while  no  colonies  were 
observed  with  pAMPM-FL-exon  (data  not  shown).  The 
ablation of the Hyg
r expression suggested the extremely 
effective processing of AMPM-FL located in the exon by 
Drosha  in  HeLa  cells.  Although  northern  blot  analysis 
showed similar levels of AMPM-FL expression from the 
exonic and intronic AMPM-FL vectors, the processing of 
AMPM-FL in the intron did not affect the expression of 
Hyg
r, suggesting that the splicing event probably precedes 
the  processing  of  AMPM-FL  by  Drosha.  Therefore,  we 
used the intronic AMPM system for further gene silencing 
experiments to achieve both effective gene silencing and 
expression of the selection marker gene. 
 
Silencing of endogenous genes by AMPM 
We  examined  whether  AMPMs  could  suppress  the 
expression of endogenous genes. We used as targets the 
human p53 gene and the human lamin A/C gene, which 
were effectively suppressed in cultured cells by shRNAs 
(Brummelkamp et al, 2002; Sui et al, 2002). The intronic 
AMPM vectors targeting the p53 and the lamin A/C genes, 
pAMPM-p53 and pAMPM-lamin A/C, respectively, were 
each transfected separately into HeLa cells. After 2-week 
selection with hygromycin, independent clones of the cells 
stably  expressing  AMPM-p53  (Figure  3A)  and  AMPM-
lamin   A/C  (Figure  3C)  were  obtained.   Western    blot   
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Figure 2. Evaluation of AMPM expression systems by 
comparison of the level of expression of AMPM and of silencing 
efficacy. A. Schematic representation of the AMPM expression 
vectors. To generate the pAMPM-FL-exon and pAMPM-FL-
intron, the AMPM-FL cassette was inserted into the 5’-UTR and 
intron of Hyg
r, respectively, in pVITRO1. Gray boxes in the 
pAMPM-FL-exon and pAMPM-FL-intron indicate the AMPM-
FL cassettes. EF1a, the promoter of the rat translation elongation 
factor 1a gene; Hyg
r, the hygromycin resistance gene; pA, the 
human elongation factor 1a polyadeylation signal. B. The 
expression of a mature artificial miRNA targeting firefly 
luciferase. The pAMPM-FL-exon and pAMPM-FL-intron 
vectors were transiently transfected into HeLa cells and the total 
RNAs were isolated. Northern blot analysis using a radiolabeled 
oligonucleotide probe detected a band around 22 nt in length 
corresponding to the antisense strand region of AMPM-FL. 
Transfer RNAs (tRNAs) served as a loading control. C. Silencing 
efficacy of exonic and intronic AMPM-FL. The pAMPM-FL-
exon, pAMPM-FL-intron or pVITRO1 vector was transfected 
with the pGL3-Control reporter vector and pRL-TK 
normalization vector into HeLa cells. Normalized luciferase 
activities were standardized relative to levels in lysates from cells 
transfected with the empty vector, pVITRO1. The values are 
means with S.E.M. (n=3). D. The influence of the insertion of the 
AMPM cassette on the expression of Hyg
r. The pAMPM-FL-
exon, pAMPM-FL-intron or pVITRO1 vector was transfected 
into HeLa cells and the total RNAs were isolated 48 hours after 
transfection. RT-PCR was carried out with primers to detect Hyg
r 
and GAPDH mRNA. GAPDH served as a control. 
 
 
 
analysis showed significantly reduced expression of each 
target  gene  in  these  cell  lines  (Figures  3B  and  3D), 
indicating  that  AMPM  can  silence  the  expression  of 
endogenous genes. 
 
Mutations in target sequences reduce RNAi efficacy of 
AMPMs 
As  natural  miRNAs  mediate  RNAi  despite  their  partial 
complementarity  to  their  targets  (Lagos-Quintana  et  al, 
2001;  Lau  et  al,  2001;  Lee  and  Ambros,  2001),  we 
assumed that AMPMs could mediate gene silencing even 
if the target sequences were mutated. HIV-1 is known to 
mutate easily, resulting in various mutant  strains.  When 
HIV-1 was targeted by RNAi in previous studies, HIV-1 
could escape from RNAi by mutations in its RNA genome 
(Boden et al, 2003; Das et al, 2004). We therefore inserted 
partial sequences of the HIV-1 integrase (IN1) and capsid 
(CA1)  genes  and  their  mutant  sequences  derived  from 
different HIV-1 strains (see Materials and Methods) into 
the 3’-UTR of the firefly luciferase gene (Figures 4A and 
4B),  and  used  them  as  reporter  vectors  to  assess  the 
sequence-specificity  of  AMPMs.  The  intronic  AMPM 
vectors,  pAMPM-IN1  and  pAMPM–CA1,  were 
constructed  to  express  AMPMs  fully  complementary  to 
IN1  and  CA1  sequences,  respectively  (Figures  4C  and 
4D).  Additionally,  to  compare  AMPMs  with  shRNAs, 
human H1 promoter-driven shRNA vectors targeting the 
IN1  and  CA1  sequences,  pH1-sh-IN1  and  pH1-sh-CA1, 
were constructed (Figures 4E and 4F). Luciferase assays 
showed  that  both  AMPMs  and  shRNAs  suppressed  the 
reporter gene expression when the target sequences were 
fully  complementary.  Introduction  of  mutations  in  the 
target  sequences  attenuated  the  suppression  of  the 
luciferase  activity  according  to  the  number  of  the 
mutations (Figures 4G and 4H), suggesting that AMPMs 
cannot silence the mismatched targets, like shRNAs. 
 
Targeting  multiple  sites  by  the  AMPM  cluster 
overcomes effects of mutations in target sequences 
How do natural miRNAs mediate RNAi effectively despite 
their partial complementarity? We next took note of the fact 
that  the  target  sites  of  natural  miRNAs  were  often 
redundant. We assumed that AMPMs could overcome the  
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effects  of  mutations  in  RNAi  by  targeting  multiple  sites 
within  a  single  mRNA.  To  examine  this  possibility,  we 
constructed a series of reporter vectors that contained both 
HIV-1 IN1 and CA1 or their mismatched sequences in the 
3’-UTR of the firefly luciferase gene (pFL-IN1-CA1, IN2-
CA2, IN3-CA3 and IN4-CA4) (Figure 5A). The design of 
these  constructs  was  based  on  the  fact  that  the  HIV-1 
integrase  and  capsid  proteins  are  encoded  in  a  single 
transcription unit of the HIV-1 genome. 
 
 
A: 
 
 
 
B: 
 
 
 
C: 
 
 
 
 
D: 
 
 
 
 
 
Figure 3. Stable gene silencing of endogenous genes by 
AMPMs. (A, C) Stable expression of AMPMs targeting 
endogenous genes. The total RNAs were isolated from stable 
transfectants of pAMPM-p53 (A) and pAMPM-lamin A/C (C). 
Northern blot analysis showed the expression of mature artificial 
miRNAs targeting p53 and lamin A/C as a single band around 22 
nt in length. tRNAs served as a loading control. (B, D) Western 
blot analysis for p53, lamin A/C and GAPDH in cells stably 
expressing AMPM-p53 (B) and AMPM-lamin A/C (D). Lanes 1 
to 3 contained samples from independently isolated cell lines. 
GAPDH served as a loading control. 
The AMPM-IN1 and AMPM-CA1 cassettes were clustered 
with interval sequences of various lengths (Figure 5B), and 
the resulting AMPM cluster vectors were transfected into 
HeLa  cells  and  total  RNAs  were  isolated.  Northern  blot 
analysis showed that mature artificial miRNAs for IN1 and 
CA1  were  produced  from  pAMPM-IN1-48-CA1  and 
pAMPM-IN1-96-CA1  as  well  as  the  monocistronic 
pAMPM-IN1 and pAMPM-CA1vectors, while the products 
from  pAMPM-IN1-0-CA1  could  not  be  detected  (Figure 
5C). The level of IN1 miRNA expression from pAMPM-
IN1-24-CA1 was relatively low, although that of CA1 was 
almost  the  same as  pAMPM-CA1.  These  results  indicate 
that  the  length  of  the  interval  sequence  between  two 
AMPMs can affect the processing of AMPMs. 
 
AMPM cluster vectors were co-transfected with the various 
pFL-IN-CA reporter vectors into HeLa cells (Figure 5D). 
When  we  used  pFL-IN1-CA1  as  a  reporter,  the  AMPM 
cluster vectors with interval sequences of 24, 48 and 96 bp 
showed  enhanced  gene  silencing  in  comparison  with  the 
monocistronic pAMPM-IN1 and pAMPM-CA1vectors. It is 
noteworthy  that  the  dicistronic  pAMPM-IN1-48  and  96-
CA1  vectors  showed  effective  suppression  even  against 
mismatched  target  sequences,  such  as  pFL-IN2-CA2  and 
pFL-IN3-CA3.  These  results  indicate  that  targeting  of 
multiple sites within a single mRNA by clusters of different 
AMPMs with an interval sequence of more than 48 nt could 
overcome  the  effects  of  mutations  in  target  sequences. 
Therefore, this AMPM technology can be a powerful tool 
for gene therapy against viruses such as HIV-1, which often 
acquire drug resistance via mutations. 
 
DISCUSSION 
 
We have shown here that our artificially designed miRNA 
precursor,  AMPM,  that  contains  restriction  sites  in  the 
loop  and  in  the  terminus  of  the  stem  region  within  the 
miRNA precursor motif, is useful as a gene silencing tool. 
Although  AMPMs  do  not  contain  any  sequence  from 
natural miRNA precursors, they are effectively processed 
(perhaps  by  Drosha  and  Dicer),  and  the  resultant  short 
products  can  mediate  effective  gene  silencing. 
Furthermore,  the  intronic  AMPM  system  enables  co-
expression  of  artificial  miRNAs  and  a  selection  marker 
gene. Although AMPM cassettes have to be cloned into 
pBS-miR  prior  to  construction  of  AMPM  expression 
vectors,  this  step  makes the  AMPM system  flexible  for 
application  to  various  expression  systems.  Actually,  we 
could easily insert AMPM cassettes into different vectors 
and  observed  coincidence  of  the  expression  of  a 
fluorescent marker protein and effective gene silencing in 
several cell lines (data not shown). 
 
The presence of  mutations in the target sequence easily 
prevents suppression of the target gene expression by both 
monocistronic  AMPMs  and  shRNAs.  This  observation 
indicates that AMPM technology can be applied to gene 
function analysis and gene therapy in a sequence-specific 
manner,  like  the  shRNA  system.  We  noticed  that 
mutations  in  the  CA target  sequences affected  silencing 
efficacy less than those in the IN target sequences. This 
may  be  due  to  the  location  of  the  mutations  within  the 
target  sequences.   In  the  CA  target  sequences,  the core   
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Figure 4. Effects of mutations in the target sequences. (A, B) The series of pFL-IN (A) and pFL-CA (B) reporter vectors containing 
the target sequences with or without mutations in downstream of the firefly luciferase gene are shown. SV40, the SV40 promoter; IN, 
a partial sequence of the HIV-1 integrase gene shown as a gray box; CA, a partial sequence of the HIV-1 p24 capsid protein gene 
shown as a gray box; pA, the SV40 late polyadenylation signal; SV40e, the SV40 enhancer. (C, D) The sequences and predicted 
secondary structures of AMPM-IN1 RNA (C) and AMPM-CA1 RNA (D). The antisense regions are indicated as red letters, and the 
modified sense regions are indicated as blue letters. (E, F) The sequences and predicted secondary structures of sh-IN1 RNA (E) and 
sh-CA1 RNA (F). The antisense regions of sh-IN1 and sh-CA1 (red letters) are the same as those of AMPM-IN1 and AMPM-CA1. 
The sense regions of sh-IN1 and sh-CA1 (blue letters) do not contain any modification, and are fully complementary to the antisense 
regions. (G, H) Silencing efficacy of shRNAs and AMPMs against the target sequences, IN (G) and CA (H), with or without 
mismatches. The pFL-IN and pFL-CA reporter vectors were cotransfected with shRNA and AMPM expression vectors targeting IN 
and CA sequences, respectively. Normalized luciferase activities were standardized relative to levels in lysates from cells transfected 
with the empty vector pH1 for shRNAs or pVITRO1 for AMPMs. * and ** indicate p<0.05 and p<0.01, respectively, in t-tests 
comparing luciferase activities of the non-mutated reporter vectors (pFL-IN1 or pFL-CA1) with the mutated reporter vectors (pFL-
IN2-4 or pFL-CA2-4). The values are means with S.E.M. (n=3).  
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Figure 5. The AMPM cluster vectors targeting different sequences within a single mRNA and their silencing efficacy. A. The 
tandemly arranged target sequences are shown as capital letters below a schematic representation of the reporter vector. The IN 
and CA target sites were linked via the interval of 6 nt long. SV40, the SV40 promoter; IN, a partial sequence of the HIV-1 
integrase gene shown as a light gray box; CA, a partial sequence of the HIV-1 p24 capsid protein gene shown as a dark gray box; 
pA, the SV40 late polyadenylation signal; SV40e, the SV40 enhancer. B. Schematic representation of the AMPM cluster vectors  
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with various lengths of interval sequences. The AMPM cassettes targeting the IN1 and CA1 sequences are shown as light gray 
and dark gray thin boxes, respectively. EF1a, the promoter of the rat translation elongation factor 1a gene; Hyg
r, the hygromycin 
resistance gene; pA, the human elongation factor 1a polyadenylation signal. C. The expression of mature artificial miRNAs from 
AMPM cluster vectors. The monocistronic AMPM vectors and AMPM cluster vectors were separately transfected into HeLa cells 
and the total RNAs were isolated. Northern blot analysis showed the shortly processed RNA derived from antisense strand region 
of AMPM-IN1 (top) and AMPM-CA1 (middle) around 22 nt in length. tRNAs served as a loading control. D. Silencing efficacy 
of each construct. The AMPM cluster vectors were co-transfected with the pFL-IN-CA reporter vectors. Normalized luciferase 
activities were standardized relative to levels in the lysate from cells transfected with the empty vector pVITRO1. * and ** 
indicate p<0.05 and p<0.01, respectively, in t-tests comparing the AMPM cluster vectors with the monocistronic AMPM vectors. 
The values are means with S.E.M. (n=3). 
 
 
 
 
sequence for miRNA-mRNA interaction, located in the 3’ 
half of the target sequences, is conserved, suggesting that 
the “seed” sequence of AMPM-CA1 is preserved (Tomari 
and Zamore, 2005). 
 
In  the  AMPM  cluster  system,  the  interval  sequence 
between  two  AMPMs  affect  the  efficacy  of  RNAi.  An 
interval  sequence  of  24  nt  between  two  AMPMs  was 
sufficient to mediate RNAi, although interval sequences of 
48 nt and 96 nt were more efficient. Northern blot analysis 
showed  the  maximum  production  of  mature  artificial 
miRNAs when the interval sequences were more than 48 
nt  in  length.  These  observations  are  consistent  with  the 
fact  that  the  interval  sequences  between  the  nearest 
miRNA  precursor  motifs  in  the  human  miR-17  cluster 
(GenBank accession no. AB176708) are around 30-60 nt 
long.  This  may  reflect  the  efficacy  of  recognition  and 
processing of AMPM by Drosha. Indeed, Zeng and Cullen 
reported  that  flanking  non-structured  sequences  are 
essential for efficient processing of pri-miRNA by Drosha 
(Zeng and Cullen, 2005). 
 
We  also  showed  that  use  of  the  AMPM  cluster  system 
overcame the effects of mutations in the multiple target 
sites  within  a  single  mRNA  (Figure  5),  suggesting  the 
possible therapeutic usefulness of the AMPM technology 
against  highly  mutable  targets  such  as  HIV-1.  Natural 
miRNAs  often  bind  to  clusters  of  repetitive  target  sites 
with  partial  complementarity  to  each  other  (Lagos-
Quintana et al., 2001; Lau et al., 2001; Lee and Ambros, 
2001), suggesting that miRNAs accomplish the fine-tuning 
of gene expression by the binding of multiple sites with 
partial complementarity to target mRNAs. 
 
The AMPM system can also be used to temporally and 
spatially suppress gene expression based on the fact that it 
is a Pol II-driven system. A recent study suggested that 
excessive  shRNA  in  cells  causes  oversaturation  of 
endogenous miRNA pathways and often results in lethality 
in  mice  (Grimm  et al.,  2006).  The  AMPM  system  may 
prevent such side effects because the transcriptional levels 
of AMPMs could be controlled by the use of appropriate 
Pol II promoters. 
 
CONCLUSIONS 
 
• A newly designed artificial miRNA, named AMPM, can 
be  efficiently  processed  perhaps  by  Drosha and  Dicer, 
despite the absence of any sequence of natural miRNA 
precursors. 
• AMPM can accomplish stable silencing of endogenous 
target genes in transfected cells. 
 
• AMPM clusters targeting multiple sites within a single 
transcript  can  overcome  mutations  in  the  target 
sequences and be applied for the suppression of highly 
mutable targets such as HIV-1. 
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